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Introduction 
Vaccinations are the greatest achievement in public health, helping to shift 
mortality rates in developed nations from communicable disease to chronic disease. 
However, in the United States (U.S.), approximately 42,000 adults and 300 children still 
die annually from vaccine-preventable diseases.1  
Cases of pertussis in the U.S. decreased dramatically after the vaccine was 
developed in the 1940s; however, since the 1980s, the number of reported cases has 
been gradually increasing. In 2010, more cases were reported than any year since 
1959.2 In 2012, the Centers for Disease Control and Prevention (CDC) recorded a 
record 48,277 cases of pertussis in America.3 Approximately half of infants who contract 
pertussis will be hospitalized, and 1% of those will die, often from a secondary bacterial 
pneumonia.3 Economic burden from childhood pertussis includes lost work days by 
parents, visits to healthcare providers, antibiotic medications, and often costs of 
hospitalization. A retrospective study in Monroe County, New York estimated that on 
average, $3561 of indirect and direct costs resulted per individual case of pertussis in 
1997.4 This cost estimate does not take into consideration the perverse inflation in 
American healthcare costs over the past 15 years, nor the associated public health 
costs of outbreak surveillance and containment.  
It is well known that vaccination has majorly decreased the incidence of pertussis 
and pertussis related deaths among Americans over the past few decades; however, in 
the past 5 years, diagnoses of pertussis have begun to increase. When pertussis 
incidence is stratified by age, it has been found that the rise is most prominent in 
adolescents aged 11-18 and adults greater than 19 years of age.5 Adolescents and 
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adults often carry a subclinical form of the disease, which means they may be less likely 
to seek medical treatment, and the number of reported cases might be falsely low.6 
These infected adults can then transmit pertussis to infants, where the bacteria cause a 
much more virulent and sometimes deadly infection.  
The cause for increased incidence of pertussis is thought to be multifactorial, but 
has not been extensively studied. One possible reason is that the efficacy of TDaP and 
DTaP vaccines is not as high as other vaccinations. Acellular pertussis vaccines (TDaP) 
replaced whole cell vaccines (DTwP) for adults and teenagers in 2005.5 Therefore, 
there are very limited data on TDaP vaccination long-term efficacy and efficacy at 
reducing transmission to infants. The childhood acellular vaccine (DTaP) has an 
efficacy of 88.7-97% immediately after completion of the immunization sequence.7,8 
However, evidence is growing that the DTaP vaccine produces a waning immunity to 
pertussis.9  
Another possible explanation is that due to increased attention to pertussis rates, 
physicians have become more diligent in testing sick children for the disease. Reasons 
a practitioner may not conduct a pertussis diagnostic test are delay in obtaining test 
results, inconvenience of collecting samples, lack of testing supplies, lack of familiarity 
with testing protocols, and cost.10 Growing pressure from the media and concerned 
parents may be motivation for providers to overcome barriers to testing. 
The focus of this study is to evaluate the possible role parental acceptance of 
vaccination plays in pertussis incidence. If fewer children are vaccinated, it is logical that 
pertussis incidence would increase. Several studies have attempted to identify factors 
that influence parents’ decisions to vaccinate adolescents with TDaP. The factor 
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commonly associated with an increased likelihood to vaccinate was provider 
recommendation, while low perceived risk of getting pertussis was the most common 
barrier to vaccination.11,12 Another barrier was that adolescents are less likely than 
young children and infants to see a healthcare provider on a regular basis.13    
Requiring vaccination in school-aged children has had tremendous impact on 
controlling preventable disease outbreaks. In 1977, a CDC study concluded that states 
requiring vaccination before school entry experienced measles incidence rates 40-50% 
lower than states that did not.14 In Kentucky, vaccination is required to attend public and 
private school. Despite the overwhelming evidence that vaccines are safe and effective, 
every state has vaccination exemption laws. All 50 states allow vaccination exemption 
for medical reasons. Children with compromised immune systems and those with 
previous allergic reactions or adverse effects associated with vaccination would fall into 
this category. In these children, vaccination may be unsafe. Several states also allow 
religious exemptions, and others allow religious and philosophical exemptions. The 
process for obtaining exemptions also varies by state.  
The recent measles outbreak at Disneyland15 has called into question the 
stringency of vaccination exemption laws. Although it seems logical to assume a 
correlation, published literature linking vaccination exemption obtainment with disease 
incidence is sparse. One study of New York state schoolchildren found that counties 
with higher rates of exemption also experienced increased incidence of pertussis 
among both vaccinated and unvaccinated children when compared to counties with low 
exemption rates.16 It is hypothesized that the same correlation would be observed in 
Kentucky, because like New York, the law allows both medical and religious 
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exemptions. The process for obtaining a religious exemption is also similar between the 
two states, requiring the parents to sign a document saying they understand the risks 
but object to vaccination for religious reasons.17,18 In Kentucky, this form must be signed 
by a healthcare provider, pharmacist, local health department or other licensed 
healthcare facility.18 In New York, the form must also be notarized.17 
The primary objective of this study was to determine if a county-level association 
existed between vaccination exemptions among school-aged children and pertussis 
incidence during the years 2004-2012. Secondarily, a regional analysis was conducted 
to determine if Appalachian counties reported higher rates of exemption than non-
Appalachian counties. The Appalachian area has many health disparities in maternal 
and child health, including lack of access to care, low socioeconomic status, and low 
educational attainment.  
Research on the health impact of legal vaccination exemptions provides valuable 
information for use when lobbying for vaccination initiatives in the legislature. If 
statistically significant associations are found, further research regarding the public 
health outcomes of parents’ decisions to vaccinate or seek exemption is highly 
warranted. This glimpse into vaccination exemptions in Kentucky could be a starting 
point for legislative reform in Kentucky. 
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Methods 
Institutional Review Board Exemption 
Because the data do not contain protected health information, the study received 
IRB exemption from both the University of Kentucky and Kentucky Cabinet for Health 
and Family Services (CHFS) Institutional Review Boards. 
Data Source 
 This study investigated the correlation between vaccination exemption in 
kindergarten and sixth grade and pertussis incidence in all 120 Kentucky counties 
between 2004 and 2012. Kentucky schools are required to submit a Commonwealth of 
Kentucky School/Facility Annual Immunization Survey to their county health 
department.19 The county health department then sends a report to the epidemiologists 
at the Immunization Program at Kentucky CHFS. This study used the epidemiological 
reports for all kindergarten and sixth grade immunizations along with statewide 
Communicable Disease Case Reports submitted to CHFS from 2004-2012.  
Study Design 
 This study retrospectively analyzed data from 120 Kentucky counties from 2004-
2012. If <50% of schools within a county submitted Immunization Surveys in a given 
year, the county was excluded from analysis. Study design closely mirrored a similar 
study published in 2013 with data from New York State.16 Annual county exemption 
rates were calculated as the percent of exemption certificates out of the total number of 
kindergarten and sixth grade students per county, as reported in the Annual 
Immunization Survey. This served as the independent variable. Overall annual 
exemption rates for the state were also calculated in this manner. The correlation 
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between exemptions and pertussis for the years 2004 through 2012 was tested using 
non-parametric Spearman analysis because data were not normally distributed. 
Changes in vaccination exemption rates and pertussis incidence over time from 2004 to 
2012 were analyzed using Friedman tests, the non-parametric analog to repeated 
measures analysis of variance (ANOVA).  
The total number of pertussis cases reported in each county over all age groups 
per year was used as the dependent variable because age-specific data were not 
available. US Census Bureau 2010 total county populations were used to calculate the 
incidence rate per 100,000.  
In addition, counties were categorized via a median split into two groups 
representing those with higher versus lower exemption rates: Above Median Group 
(AMG) and Below Median Group (BMG). A non-parametric Mann-Whitney U test was 
performed to test for a statistically significant difference in pertussis incidence between 
the two groups. 
Finally differences in pertussis incidence and exemptions between Appalachian 
and non-Appalachian counties were also analyzed using non-parametric Mann-Whitney 
U tests. 
 All analyses were conducted using SPSS (Version 22) software and all statistical 
tests were two-tailed with alpha set at 0.05. 
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Results 
Descriptive Statistics 
 Of 1080 total reported cases (i.e. county in a given year), 937 were included for 
analysis and 143 were excluded. The mean exemption rate was 0.5058 + 0.656 
exemptions per 100 students. The median exemption rate was 0.3656 per 100 students. 
The distribution of exemptions was skewed to the right and therefore non-parametric 
tests were used to test for significant associations. Descriptive statistics are 
summarized in Tables 1 and 2.  
Correlation Analysis 
 A non-parametric Spearman test showed a statistically significant correlation 
between overall vaccination exemptions and pertussis incidence (rho=0.176, p<0.001).  
Time Analysis 
 Non-parametric Friedman tests were used to analyze difference over time in the 
rates of vaccination exemption and pertussis in the 120 counties. There was a 
statistically significant difference in vaccination exemption rates over the nine year 
period, Χ2(8) = 119.576, p<0.001. There was also a statistically significant difference in 
pertussis incidence over the nine-year period, Χ2(8) = 192.867, p<0.001. Both 
vaccination exemption rates and pertussis incidence rates tended to increase over time. 
The attached maps provide a visual representation of change in vaccination exemptions 
in Kentucky counties in 2004 as compared to 2012 (Figures 1 and 2). 
Median Split Analysis 
 The Below-Median Group (BMG) was defined as all cases with an exemption 
rate <0.3656 per 100 students (n=468). The Above-Median Group (AMG) was defined 
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as all cases with an exemption rate >0.3656 per 100 students (n=469). The BMG mean 
pertussis incidence was 0.0044 + 0.019 per 100 people, compared to the AMG mean of 
0.0066 + 0.014 per 100 people. Median pertussis incidence in groups BMG and AMG 
were 0.00015 and 0.000 per 100 people; the distributions in the two groups differed 
significantly (Mann-Whitney U=93595). Figure 3 illustrates the distribution of exemption 
rate frequencies in both groups, in which the AMG distribution is shifted slightly to the 
right compared to the BMG distribution.  
Appalachian Analysis 
 The average pertussis incidence in Appalachian cases was 0.00531 + 0.021 per 
100 people (n=416). The average pertussis incidence in non-Appalachian cases was 
0.00568 + 0.013 per 100 people (n=521). Median incidence in both groups was 0.000; 
however, the distributions in the two groups differed significantly (Mann-Whitney U = 
96867, P=0.001). The attached histogram illustrates the distribution of pertussis rates in 
the two groups (Figure 4), in which the proportion of non-zero incidence was higher in 
non-Appalachian counties. 
 The average vaccination exemption rate in Appalachian counties was 0.4464 + 
0.622 per 100 students. The average vaccination exemption rate in non-Appalachian 
counties was 0.5533 + 0.677. Median exemption rates in Appalachian and non-
Appalachian groups were 0.2834 and 0.4189 respectively. The distributions in the two 
groups differed significantly (Mann-Whitney U= 92481, P<0.05). The attached histogram 
illustrates the distribution of vaccination exemptions in the two groups (Figure 5), in 
which the proportion of cases with non-zero exemption rates was higher in non-
Appalachian counties. 
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Discussion 
 Vaccinations are a controversial political and social topic. This study found that in 
counties with higher rates of vaccination exemptions in school-aged children, 
significantly higher pertussis incidence rates were observed. This finding mirrors the 
results found in New York in 2000-2011.15 Research such as this is important as public 
health advocates argue for more stringent childhood vaccination laws.  
 Additional analyses revealed that non-Appalachian counties reported higher 
rates of vaccination exemption and also slightly higher rates of pertussis incidence than 
non-Appalachian counties. This result supports the theory that more exemptions are 
filed in high-income areas. This is a refreshing contrast to most published literature on 
health in Appalachian areas and shows that although health disparities exist in the area, 
pertussis incidence is not disproportionately higher in Appalachian counties. 
 Strengths of this study include a large sample size spanning several years of 
collection. Also, exemption data were a census of schools for the given time period, not 
a random sample. However, study limitations should be considered. Due to 
inconsistencies in county-level reporting of data and state-level maintenance of records, 
one case was defined as one county during one year of data collection. Therefore, the 
same county population was used to calculate 9 different pertussis incidence rates, 
even though countywide immunity would change from year to year as vaccination 
trends changed. Data were structured in this way in order to maximize the sample size 
and streamline statistical analyses. Future research using more complex longitudinal 
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analyses with an accumulation of exemptions over time may yield more accurate 
statistical results.  
 For future research, the data set compiled from the Commonwealth of Kentucky 
School/Facility Annual Immunization Survey could yield a wealth of information about 
Kentucky vaccinations. For example, the same study could be repeated using rate of 
reported Tdap/Dtap vaccination as the independent variable instead of filed vaccine 
exemption. This would factor in students who were not vaccinated or who did not 
receive the entire vaccine series, but whose parents did not take the steps to file for 
exemption. In theory, these students would be required to complete the vaccine series 
in order to attend school. However, that is often not the case. This topic would 
especially be interesting to study in Appalachian counties because it may better address 
barriers to vaccination.   
 This research serves as a valuable stepping-stone for behavioral research 
regarding parental decisions to abstain from vaccination. Such research is pivotal when 
developing health initiatives and programs promoting vaccination of Kentucky children. 
The current findings also provide ammunition for reform of vaccination exemption laws 
in Kentucky. Changing the law to only allow for medical exemptions and/or to increase 
the complexity of applying for a religious exemption could potentially increase 
vaccination rates in Kentucky schoolchildren. 
 Many factors may influence a parent’s decision to vaccinate his or her child. 
Although the current study did not examine parental decisions, results suggest that 
higher rates of exemption sought by parents have an epidemiological impact on the 
health of our state. It is in the best interest of our Commonwealth that public health 
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officials and healthcare providers continue to stress the importance of vaccinations in 
order to keep preventable communicable diseases, such as pertussis, at bay.  
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Table 1: Descriptive Statistics of Vaccination Exemptions and Pertussis Incidence in 
Kentucky Counties, 2004-2012 
 Overall Above- Median 
Groupa 
Below- Median 
Groupb 
Total Cases 
 
937 
 
469 468 
Mean Exemption 
Rate  
(per 100 students) 
 
0.508 + 0.656 
 
0.8907 + 0.738 
 
0.1202 + 0.133 
 
Median Exemption 
Rate  
(per 100 students) 
 
0.3656 0.6977 
 
0.0502 
 
Range of Exemption 
Rates  
(per 100 students) 
 
0.0 000 – 5.672 
 
0.3656 – 5.672  
 
0.0000 – 0.3636 
 
Mean Pertussis 
Rate  
(per 100 people) 
 
0.0055 + 0.0174 
 
0.0066 + 0.0147 
 
0.0044 + 0.0197 
 
Median Pertussis 
Rate  
(per 100 people) 
 
0.00 0.00 0.00 
Range of Pertussis 
Rates  
(per 100 people) 
 
0.0 – 0.3680 
 
0.0 – 0.1587 
 
0.0 – 0.3680 
 
aAbove-Median Group refers to cases with vaccination exemption rates greater than or 
equal to the overall median of 0.3656 per 100 students. 
bBelow-Median Group refers to cases with vaccination exemption rates less than the 
overall median of 0.3656 per 100 students. 
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Table 2: Descriptive Statistics of Vaccination Exemptions and Pertussis Incidence in 
Appalachian versus Non-Appalachian Counties in Kentucky, 2004-2012 
 Overall Appalachian Non-Appalachian 
Total Cases 
 
937 
 
416 521 
Mean Exemption 
Rate  
(per 100 students) 
 
0.508 + 0.656 
 
0.4464 + 0.622 
 
0.5532 + 0.678 
Median Exemption 
Rate  
(per 100 students) 
 
0.3656 0.2834 
 
 
0.4190 
Range of Exemption 
Rates  
(per 100 students) 
 
1.0 000 – 5.672 
 
0.0 000 – 5.10 
 
00000 – 5.67 
Mean Pertussis 
Rate  
(per 100 people) 
 
0.0055 + 0.0174 
 
0.0053 + 0.0214 
 
0.0057 + 0.0134 
Median Pertussis 
Rate  
(per 100 people) 
 
0.00 0.00 0.00 
Range of Pertussis 
Rates  
(per 100 people) 
 
0.0 – 0.3680 
 
0.0 – 0.3680  
 
0.0 – 0.1587  
Figure 1: 2004 County-Level Vaccination Exemption Rates in Kentucky 
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Figure 2: 2012 County-Level Vaccination Exemption Rates in Kentucky 
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Figure 3: 
 
Note: Below the Median refers to the Below-Median Group (BMG), including cases with 
vaccination exemption rates less than the overall median of 0.3656 per 100 students. 
Above the median refers to the Above-Median Group (AMG), including cases with 
vaccination exemption rates greater than or equal to the overall median of 0.3656 per 
100 people. 
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Figure 4:
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Figure 5:
 
